최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한한방내과학회지 = The journal of internal Korean medicine, v.38 no.4, 2017년, pp.443 - 454
정민정 (우석대학교 한의과대학 소아과학교실) , 강기완 (우석대학교 한의과대학 한방내과학교실) , 강자연 (우석대학교 한의과대학 한방내과학교실) , 윤지현 (우석대학교 한의과대학 본초학교실) , 최유민 (우석대학교 한의과대학 침구학교실) , 김홍준 (우석대학교 한의과대학 방제학교실) , 선승호 (상지대학교 한의과대학 한방내과학교실) , 장인수 (우석대학교 한의과대학 한방내과학교실)
Objectives: This study assessed the application of Oryung-san (Wuling-san or Gorei-san), a common diuretic in traditional medicine, as an antihypertensive agent. Methods: Experimental studies of the pharmacological properties of Oryung-san, including diuretic action and lowering effects on blood pre...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
서양의학에서 고혈압 약물 치료의 원칙은? | 서양의학에서 고혈압 약물 치료의 원칙은 다음과 같다. 2기 고혈압(≥160/100 mmHg) 또는 고위험 (표적장기손상, 심뇌혈관질환) 1기 고혈압(≥140/90mmHg)은 생활습관 개선을 시작함과 동시에 항고혈압제를 투여할 것을 권고하고 있으며, 심뇌혈관 질환이나 표적장기 손상이 없는 1기 고혈압은 수개월 간의 생활습관 개선 후 목표혈압 이하로 혈압조절이 안된다면 약물치료를 시작할 것을 권고하고 있다10. 표적장기 손상이 없는 1기 고혈압은 단일제로 시작하고 2-3개월 후 목표혈압 이하로 조절이 안되면 약제의 용량을 올리거나 약제를 추가하는 병용요법을 고려하며, 표적장기 손상이 있는 1기 고혈압 또는 2기 고혈압은 처음부터 2제 이상의 병용요법을 고려한다10. 고혈압의 일차 선택약은 안지오텐신전환효소억제제(ACEI), ARB, CCB, 티아지드계 이뇨제, 베타 차단제(BB)이며, 병용요법으로는 ARB와 CCB, ARB와 티아지드계 이뇨제, CCB와 티아지드계 이뇨제가 1차로 권고되는 약물의 조합이다10. | |
고혈압은 어떻게 진단하는가? | 수축기 혈압이 140 mmHg 이상 또는 확장기 혈압이 90 mmHg 이상인 경우 고혈압으로 진단하며4,국내 뇌혈관질환 환자의 35%, 심혈관질환 환자의 21%를 고혈압이 차지할 정도로 기여가 큰 위험인자라고 보고되고 있어5,6, 지속적인 치료와 관리가 필요한 중요한 질병이다. 보건복지부의 국민건강통계에 의하면, 만 30세 이상의 고혈압 환자 비율이 1998년 29. | |
고혈압이란? | 고혈압은 만성 순환기질환 중에서 발생빈도가 가장 높은 질환으로, 뇌혈관 질환, 심혈관 질환, 신장 질환, 동맥경화증 등의 중요한 위험인자이다1-3. |
Choi SW, Han SW, Ok JS, Yoo BS, Shin MS, Park SH, et al. A multicenter cohort study of primary hypertension in Korea: study design and interim analysis of the Korean registry of target organ damage in hypertension(KorHR). Clin Hypertens 2017;23(1):16.
Whelton PK. Epidemiology of hypertension. Lancet 1994;344(8915):101-6.
Guo X, Zhou B, Nishimura T, Teramukai S, Fukushima M. Clinical effect of qigong practice on essential hypertension: a meta-analysis of randomized controlled trials. Journal of alternative and complementary medicine. J Altern Complement Med 2008;14(1):27-37.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
Shin J, Park JB, Kim KI, Kim JH, Yang DH, Pyun WB, et al. 2013 Korean Society of Hypertension guidelines for the management of hypertension: part I-epidemiology and diagnosis of hypertension. Clin Hypertens 2015;21:1.
KPMA. Pharmaceutical Industry Data Book. 2016. [accessed 2017 Aug. 25] URLhttp://www.kpma.or.kr/attach/1611_KPMA%20DATA%20BOOK_ver1.pdf
E-Daily News. Development of hypertension drug '3 in 1 combination'. [accessed 2017 Aug. 25] URLhttp://www.edaily.co.kr/news/NewsRead.edy?SCDJC61&newsid01341526612814560&DCDA00306&OutLnkChkY
Health Insurance review & assessment service. Medical Statistics Index. 2015. [accessed 2017 Aug. 25] URLhttps://www.khiss.go.kr/board/bbs_read.jsp?tnameMINBOARD358&bbsidB301&cat_bbsid&bbs_seq434&jkey&jword&pg4&htxt_code12536978062659050219061516896964&wj_vcs&reverseNum182&forwardNum31
Korean Academy of Medical Sciences. Evidence-based Guideline for Hypertension in Primary Care. 2014. [accessed 2017 Aug. 25] URLhttp://www.guideline.or.kr
The education committee of Korean medicine college for Herbal formula science. Herbal formula science. Seoul: Yeonglimsa; 2003, p. 504-6.
Zhao YY, Xie RM, Chao X, Zhang Y, Lin RC, Sun WJ. Bioactivity-directed identification of diuretic compounds from Polyporus umbellatus. J Ethropharmacol 2009;126(1):184-7.
Yuan D, Mori J, Komatsu KI, Makino T, Kano Y. An anti-aldosteronic diuretic component(drain dampness) in Polyporus sclerotium. Biol Pharm Bull 2004;27(6):867-70.
Zhu YP. Chinese Materia Medica Chemistry: Pharmacology and Applications. Amsterdam: Harwood Academic Publishers; 1998, p. 501-2.
Wu ZL, Ren H, Lai WY, Lin S, Jiang RY, Ye TC, et al. Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure. J Ethropharmacol 2014;155(1):563-71.
Feng YL, Chen H, Tian T, Chen DQ, Zhao YY, Lin RC. Diuretic and anti-diuretic activities of the ethanol and aqueous extracts of Alismatis rhizoma. J Ethropharmacol 2014;154(2):386-90.
Chen DQ, Feng YL, Tian T, Chen H, Yin L, Zhao YY, et al. Diuretic and anti-diuretic activities of fractions of Alismatis rhizoma. J Ethropharmacol 2014;157:114-8.
Hattori T, Nishimura H, Makino B, Shindo S, Kawamura H. Sairei-to inhibits the production of endothelin-1 by nephritic glomeruli (2): alisols, possible candidates as active compounds. Nihon Jinzo Gakkai Shi 1998;40(2):33-41.
Satoh K, Yasuda I, Nagai F, Ushiyama K, Akiyama K, Kano I. The effects of crude drugs using diuretic on horse kidney (Na++K+)-adenosine triphosphatase. Yakugaku Zasshi 1991;111(2):138-45.
Lee SI. Studies on the diuretic action of Oryeongsan and Kami-Oryeongsan. Kor J Pharmacog 1981;12(1):31-43.
Ahn YM. Oryeongsan has different effects on water and electrolyte balance by routes of administration. Master's Thesis, Wonkwang University 2011:58.
Ahn YM, Cho KW, Kang DG, Lee HS. Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin-angiotensin-aldosterone system in rats. J Ethnopharmacol 2012;141:780-5.
Kim KA, Min YK, Lee HS, Ryu DG. Effects of the gastric administration of Oryungsan water extract on the renal function, plasma renin activity and plasma levels of atrial natriuretic peptide in the rats. J Oriental Physiology 1996;11(2):89-98.
Kurita T, Nakamura K, Tabuchi M, Orita M, Ooshima K, Higashino H. Effects of Gorei-san: a traditional Japanese Kampo medicine, on aquaporin 1, 2, 3, 4 and V2R mRNA expression in rat kidney and forebrain. J Med Sci 2011;11(1):30-8.
Ahn YM. Effects of Oryeongsan on Regulation of Renal Function and Hormonal Balance in Hypertensive Rats. Ph.D. Thesis, Wonkwang University 2016:82.
Han YP, Wang NS, Mi SQ, Liu QD. Effect of Wuling powder on rats with renal hypertension. Zhong Xi Yi Jie He Xue Bao 2003;1(4):285-8.
Cho DH, Doo HK, Kim IS, Sohn SY, Chung YH, Han YH, et al. Effects of Gamioryeongsan, Gamiyukmijihwangtang and vinegar on rats with acute renal failure induced by gentamicin sulfate. J Kyung Hee Univ 1991;7(3):287-311.
Ahn SY. Effects of Oryeongsan and Yukmijihwangtang on rats with acute renal failure induced by gentamicin sulfate. Master's Thesis, Kyunghee University 1993:59.
Lee MG. Effects of Paljungsan and Kamioryungsan on rats with acute renal failure induced by gentamicin sulfate. Master's Thesis, Kyunghee University 1997:43.
Tsumura & Co. Tsumura Goreisan extract granules for ethical use. Revised: May 2007(4th version) [accessed 2017 Aug. 25] URLhttp://www.tsumura.co.jp/english/products/pi/JPR_T017.pdf
Zhang Y, Wang N, Liu Q, YE S, OU W. Evaluation of Toxicity of WLS. Chinese Journal of Modern Drug Application 2008;2(12):16-8.
Lee H, Kang K, Lee E, Lee S, Han C, Jang I. A Systematic Review on Antihypertensive Effects of Oryeong-san. Korean J Orient Int Med 2013;34(3):289-97.
Peon X, Cheng X, Sung R, Kong B. Clinical observation on 80 cases of primary hypertension treated by Amlodipine and Danqi Wuling powder. Yunnan Journal of Traditional Chinese Medicine and Materia Medica 2011;32(9):23-4.
Quan Y. Investigation of renal protective effect in early hypertensive renal injury by supplemented Wuling San combined with Liuweidihuang decoction. Capital Medicine 2011;(08):44-6.
Fan Y. Clinical research on treatment of Wuling power on metabolic syndrome. Guangzhou University of Chinese Medicine 2012:1-50.
Jang I, Kim M, Han H, Jeong M, Kang S. Treatment of primary hypertension by Oryung-san monotherapy: a case report. J Internal Korean Med 2014;35(1):106-10.
Jeon U. Principles and Practice of Diuretic Therapy. Korean J Med 2011;80(1):8-14.
Ding XQ, Pan Y, Wang X, Ma YX, Kong LD. Wuling San ameliorates urate under-excretion and renal dysfunction in hyperuricemic mice. Chin J Nat Med 2013;11(3):214-21.
Yang Y, Zhang DM, Liu JH, Hu LS, Xue QC, Ding XQ, et al. Wuling San protects kidney dysfunction by inhibiting renal TLR4/MyD88 signaling and NLRP3 inflammasome activation in high fructose-induced hyperuricemic mice. J Ethnopharmacol 2015;169:49-59.
Takei H, Nakai Y, Hattori N, Yamamoto M, Takeda S, Yamamoto M, et al. The herbal medicines Saireito and Boiogito improve the hypertension of pre-eclamptic rats induced by Nomega-Nitro-L-arginine methyl ester. Phytomedicine 2007;14:591-600.
Qiu Y, Yu F, Zhang W, Zhou M. Clinical observation on effect of Wuling powder on electrolyte in patients with nephrotic syndrome. CJGMCM 2016;31(18):2665-8.
Kim SY. Influence of Goryeosin infusion solution on the change of serum electrolytes in rats. Dajeon Univ 1990:1-38.
Ito Y. Pathophysiology of the Goreisan show lowering of osmolality set point. Japanese Journal of Oriental Medicine 1978;28:91-9.
Isohama Y. Modulation of aquaporin water channel function by Kampo medicines. Kampo and the newest therapy 2008;17:27-35.
Sakamoto A, Kuriyama K, Konoshita Y, Hodaka K, Kainuma M. A case of hyponatremia complicated with small cell lung cancer successfully treated with Goreisan. Kampo Med 2015;66(2):124-30.
The education committee of Korean medicine college for cardiology and neurology. The cardiology and neurology in Korean medicine Vol. 2. Seoul: Woori medical books; 2016, p. 196-8, 366-75.
The Korean society of hypertension. Hypertension management guidelines. [accessed 2017 Aug. 25] URLhttp://www.koreanhypertension.org
Chae S. Is diuretics the top priority? Cardiovascular Update 2003;5(3):11-5.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.